The impact of COVID-19 pandemic on nosocomial multidrug-resistant bacterial bloodstream infections and antibiotic consumption in a tertiary care hospital

Basit Öğe Kaydı
dc.authoridTanriverdi, Elif Seren/0000-0002-0449-0356
dc.authoridZarakolu, Pınar/0000-0003-4918-4085
dc.authoridTelli Dizman, Gülçin/0000-0001-8195-3345
dc.authoridUzun, Omrum/0000-0003-4721-0139
dc.authoridMetan, Gokhan/0000-0002-2676-4557
dc.authoridOtlu, Baris/0000-0002-6220-0521
dc.authorwosidTanriverdi, Elif Seren/ABE-4472-2021
dc.authorwosidZarakolu, Pınar/KEH-6744-2024
dc.authorwosidTelli Dizman, Gülçin/ABV-3036-2022
dc.contributor.authorMetan, Gokhan
dc.contributor.authorCuha, Mervenur Demir
dc.contributor.authorHazirolan, Gulsen
dc.contributor.authorDizman, Gulcin Telli
dc.contributor.authorTanriverdi, Elif Seren
dc.contributor.authorOtlu, Baris
dc.contributor.authorTas, Zahit
dc.date.accessioned2024-08-04T21:02:05Z
dc.date.available2024-08-04T21:02:05Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractWe investigated the change in the epidemiology of nosocomial blood-stream infections (BSIs) caused by multidrug-resistant bacteria during Coronavirus Disease (COVID-19) and antibiotic consumption rates at a pandemic hospital and at the Oncology Hospital which operated as COVID-19-free on the same university campus. Significant increases in the infection density rate (IDRs) of BSIs caused by carbapenem-resistant Acinetobacter baumannii (CRAB) and ampicillin-resistant Enterococcus faecium (ARE) were detected at the pandemic hospital, whereas car-bapenem-resistant Klebsiella pneumoniae BSIs were increased at the non-pandemic Oncology Hospital. Pulsed field gel electrophoresis showed a polyclonal outbreak of CRAB in COVID-19 intensive care units. Antibiotic consumption rates were increased for almost all antibiotics, and was most significant for meropenem at both of the hospitals. In-creased IDRs of CRAB and ARE BSIs as well as an increased consump-tion rate of broad-spectrum antibiotics emphasize the importance of a multimodal infection prevention strategy combined with an active anti-biotic stewardship program.en_US
dc.identifier.doi10.3205/dgkh000418
dc.identifier.issn2196-5226
dc.identifier.pmid36157382en_US
dc.identifier.urihttps://doi.org/10.3205/dgkh000418
dc.identifier.urihttps://hdl.handle.net/11616/104465
dc.identifier.volume17en_US
dc.identifier.wosWOS:000849220000001en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherGerman Medical Science-Gmsen_US
dc.relation.ispartofGms Hygiene and Infection Controlen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCOVID-19en_US
dc.subjectSARS-CoV-2en_US
dc.subjectantibacterial resistanceen_US
dc.subjectbacteremiaen_US
dc.subjectantibiotic consumptionen_US
dc.titleThe impact of COVID-19 pandemic on nosocomial multidrug-resistant bacterial bloodstream infections and antibiotic consumption in a tertiary care hospitalen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu